Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Profound Medical (PROF) reported a Q3 loss of $0.38 per share, missing the Zacks Consensus Estimate of a $0.33 loss. This is a larger loss compared to $0.26 per share a year ago.
November 08, 2024 | 12:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Profound Medical reported a larger-than-expected Q3 loss of $0.38 per share, missing the Zacks Consensus Estimate of $0.33 and widening from last year's $0.26 loss.
The larger-than-expected loss and the widening of losses compared to the previous year are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100